China-Biotics, Inc. Appoints New Vice...( SHANGHAI Oct. 30 Asia-FirstCall/ ...)

SHANGHAI, Oct. 30 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced the appointment of Dr. Tom Gu as Vice President, effective November 2. In this role, Dr. Gu will oversee the development of China Biotics' probiotics products in order to meet the growing demand the Company has seen from China and the global market.

Dr. Gu has an impressive background in biochemistry and pathology with extensive practical experience in U.S. FDA-certified medical applications obtained from his work at China-based medical companies over the past eight years. Previously, Dr. Gu served as project manager for Life Technologies Corporation in the United States. Dr. Gu graduated from the University of Arizona with a Ph.D in molecular medicine. He received an EMBA from North Virginia University and a Bachelor of Science degree in biochemistry from Jilin University of China. Dr. Gu has also conducted postdoctoral research with the National Institutes of Health and previously served as a director of the United States Federation for Culture Collections. In addition, Dr. Gu is currently a member of the Expert Committee of the Shanghai Zhangjiang Bio-Pharmaceutical Base.

"We are very excited to have someone of Dr. Gu's caliber join us and lead our research and development team," said Mr. Jinan Song, Chairman and Chief Executive Officer of China Biotics. "His impressive academic achievements and practical experience will enhance and solidify our R&D capabilities, which will be of critical importance as we expand the scale of our operations. We are currently in trial production at our new 150 metric ton probiotics facility, which
'/>"/>